Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010, Article ID 287248, 5 pages
http://dx.doi.org/10.1155/2010/287248
Review Article

Vascular Complications of Systemic Sclerosis during Pregnancy

Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road, Suite 203, Palo Alto, CA 94304, USA

Received 15 April 2010; Accepted 2 July 2010

Academic Editor: Virginia D. Steen

Copyright © 2010 Eliza F. Chakravarty. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bernatsky, L. Joseph, C. A. Pineau, P. Belisle, M. Hudson, and A. E. Clarke, “Scleroderma prevalence: demographic variations in a population-based sample,” Arthritis Care and Research, vol. 61, no. 3, pp. 400–404, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. D. Mayes, J. V. Lacey Jr., J. Beebe-Dimmer, B. W. Gillespie, B. Cooper, T. J. Laing, and D. Schottenfeld, “Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population,” Arthritis and Rheumatism, vol. 48, no. 8, pp. 2246–2255, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. L. Carbillon, M. Uzan, and S. Uzan, “Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation,” Obstetrical and Gynecological Survey, vol. 55, no. 9, pp. 574–581, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Ganzevoort, A. Rep, G. J. Bonsel, J. I. P. De Vries, and H. Wolf, “Plasma volume and blood pressure regulation in hypertensive pregnancy,” Journal of Hypertension, vol. 22, no. 7, pp. 1235–1242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. L. Thornburg, S.-L. Jacobson, G. D. Giraud, and M. J. Morton, “Hemodynamic changes in pregnancy,” Seminars in Perinatology, vol. 24, no. 1, pp. 11–14, 2000. View at Google Scholar · View at Scopus
  6. M. C. Frederiksen, “Physiologic changes in pregnancy and their effect on drug disposition,” Seminars in Perinatology, vol. 25, no. 3, pp. 120–123, 2001. View at Google Scholar · View at Scopus
  7. B. Ramsay, A. De Belder, S. Campbell, S. Moncada, and J. F. Martin, “A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia,” European Journal of Clinical Investigation, vol. 24, no. 1, pp. 76–78, 1994. View at Google Scholar · View at Scopus
  8. J. R. Karlen and W. A. Cook, “Renal scleroderma and pregnancy,” Obstetrics and Gynecology, vol. 44, no. 3, pp. 349–354, 1974. View at Google Scholar · View at Scopus
  9. S. V. Sood and H. G. Kohler, “Maternal death from systemic sclerosis,” Journal of Obstetrics and Gynaecology of the British Commonwealth, vol. 77, no. 12, pp. 1109–1112, 1970. View at Google Scholar · View at Scopus
  10. D. Younker and B. Harrison, “Scleroderma and pregnancy,” British Journal of Anaesthesia, vol. 57, no. 11, pp. 1136–1139, 1985. View at Google Scholar · View at Scopus
  11. L. Scarpinato and A. H. Mackenzie, “Pregnancy and progressive systemic sclerosis. Case report and review of the literature,” Cleveland Clinic Quarterly, vol. 52, no. 2, pp. 207–211, 1985. View at Google Scholar · View at Scopus
  12. M. Østensen, “Scleroderma pregnancy: can the price be too high to pay?” Clinical and Experimental Rheumatology, vol. 26, no. 6, pp. 979–981, 2008. View at Google Scholar · View at Scopus
  13. V. D. Steen, C. Conte, N. Day, R. Ramsey-Goldman, and T. A. Medsger Jr., “Pregnancy in women with systemic sclerosis,” Arthritis and Rheumatism, vol. 32, no. 2, pp. 151–157, 1989. View at Google Scholar · View at Scopus
  14. V. D. Steen and T. A. Medsger Jr., “Fertility and pregnancy outcome in women with systemic sclerosis,” Arthritis and Rheumatism, vol. 42, no. 4, pp. 763–768, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. V. D. Steen, “Pregnancy in scleroderma,” Rheumatic Disease Clinics of North America, vol. 33, no. 2, pp. 345–358, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. Chung, R. L. R. Flyckt, I. Colón, A. A. Shah, M. Druzin, and E. F. Chakravarty, “Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease,” Lupus, vol. 15, no. 9, pp. 595–599, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Miniati, S. Guiducci, F. Mecacci, G. Mello, and M. Matucci-Cerinic, “Pregnancy in systemic sclerosis,” Rheumatology, vol. 47, pp. iii16–iii18, 2008. View at Google Scholar · View at Scopus
  18. E. F. Chakravarty, D. Khanna, and L. Chung, “Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease,” Obstetrics and Gynecology, vol. 111, no. 4, pp. 927–934, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. R. Resnik, “Intrauterine growth restriction,” Obstetrics and Gynecology, vol. 99, no. 3, pp. 490–496, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Batal, R. T. Domsic, A. Shafer, T. A. Medsger Jr., L. P. Kiss, P. Randhawa, and S. Bastacky, “Renal biopsy findings predicting outcome in scleroderma renal crisis,” Human Pathology, vol. 40, no. 3, pp. 332–340, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. W. O. Cooper, S. Hernandez-Diaz, and S. Hernandez-Diaz, “Major congenital malformations after first-trimester exposure to ACE inhibitors,” The New England Journal of Medicine, vol. 354, no. 23, pp. 2443–2451, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T. R. Easterling, D. B. Carr, C. Davis, C. Diederichs, D. A. Brateng, and B. Schmucker, “Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy,” Obstetrics and Gynecology, vol. 96, no. 6, pp. 956–961, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. C. C. Mok, T. H. Kwan, and L. Chow, “Scleroderma renal crisis sine scleroderma during pregnancy,” Scandinavian Journal of Rheumatology, vol. 32, no. 1, pp. 55–57, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. F. M. Wigley, J. A.C. Lima, M. Mayes, D. McLain, J. L. Chapin, and C. Ward-Able, “The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study),” Arthritis and Rheumatism, vol. 52, no. 7, pp. 2125–2132, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. E. Hachulla, P. de Groote, V. Gressin et al., “The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France,” Arthritis and Rheumatism, vol. 60, pp. 1831–1839, 2009. View at Google Scholar
  26. B. P. Madden, “Pulmonary hypertension and pregnancy,” International Journal of Obstetric Anesthesia, vol. 18, no. 2, pp. 156–164, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Huang and E. R. H. DeSantis, “Treatment of pulmonary arterial hypertension in pregnancy,” American Journal of Health-System Pharmacy, vol. 64, no. 18, pp. 1922–1926, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. E. Bédard, K. Dimopoulos, and M. A. Gatzoulis, “Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?” European Heart Journal, vol. 30, no. 3, pp. 256–265, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. G. S. Zavorsky, A. B. Blood, G. G. Power, L. D. Longo, R. Artal, and E. J. Vlastos, “CO and NO pulmonary diffusing capacity during pregnancy: safety and diagnostic potential,” Respiratory Physiology and Neurobiology, vol. 170, no. 3, pp. 215–225, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. M. Higton, C. Whale, M. Musk, and E. Gabbay, “Pulmonary hypertension in pregnancy: two cases and review of the literature,” Internal Medicine Journal, vol. 39, no. 11, pp. 766–770, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. Goland, F. Tsai, M. Habib, M. Janmohamed, T. M. Goodwin, and U. Elkayam, “Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension,” Cardiology, vol. 115, no. 3, pp. 205–208, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. H. H. Leuchte, M. Schwaiblmair, R. A. Baumgartner, C. F. Neurohr, T. Kolbe, and J. Behr, “Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension,” Chest, vol. 125, no. 2, pp. 580–586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. L. E. Kahl, C. Blair, R. Ramsey-Goldman, and V. D. Steen, “Pregnancy outcomes in women with primary Raynaud's phenomenon,” Arthritis and Rheumatism, vol. 33, no. 8, pp. 1249–1255, 1990. View at Google Scholar · View at Scopus
  34. L. Ibba-Manneschi, M. Manetti, and M. Manetti, “Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings,” Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 458–461, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. K. Papakonstantinou, D. Hasiakos, and A. Kondi-Paphiti, “Clinicopathology of maternal scleroderma,” International Journal of Gynecology and Obstetrics, vol. 99, no. 3, pp. 248–249, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. B. J. Doss, S. M. Jacques, M. D. Mayes, and F. Qureshi, “Maternal scleroderma: placental findings and perinatal outcome,” Human Pathology, vol. 29, no. 12, pp. 1524–1530, 1998. View at Google Scholar · View at Scopus